IDiyas

For the Inventor, By the Inventor

Ikeda, Japan

Haruki Nishimura

USPTO Granted Patents = 8

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 95(Granted Patents)


Location History:

  • Ikeda, JA (1976 - 1978)
  • Ikeda, JP (1979 - 1984)

Company Filing History:

goldMedal8 out of 129 
 
Dainippon Pharmaceutical Company, Limited
 patents

Years Active: 1976-1984

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4447439 - 2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, (1984-05-08),
2. 4248883 - 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives and salts (1981-02-03),
3. 4162316 - 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and (1979-07-24),
4. 4080453 - 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and (1978-03-21),
5. 4029780 - 3-Piperazinyl 1,2,4-benzothiadiazine 1,1-dioxide derivatives their (1977-06-14),
6. 3988456 - 1,2-Diphenylethanolamine derivatives and their salts and the preparation (1976-10-26),
7. 3957788 - 1-Substituted-4-(1,2-diphenylethyl)piperazine derivatives and their (1976-05-18),
8. 3948928 - 3-Substituted-1,2-benzisoxazoles and pharmaceutically acceptable acid (1976-04-06),

Title: Haruki Nishimura: Innovator in Pharmaceutical Chemistry

Introduction

Haruki Nishimura is a prominent inventor based in Ikeda, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of eight patents to his name, he has made remarkable advancements in the field of medicinal compounds.

Latest Patents

Nishimura's latest patents include innovative compounds such as 2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives. These compounds exhibit potent anticholinergic antispasmodic activity while minimizing side effects like mydriasis and tachycardia. Another notable patent is for 1-(3-Mercapto-2-methylpropanoyl)prolyl amino acid derivatives, which demonstrate excellent antihypertensive activity. These advancements highlight his commitment to developing effective pharmaceutical solutions.

Career Highlights

Haruki Nishimura is associated with Dainippon Pharmaceutical Company, Limited, where he has played a crucial role in research and development. His work has significantly impacted the pharmaceutical industry, particularly in creating compounds that address various medical conditions.

Collaborations

Nishimura has collaborated with esteemed colleagues such as Masanao Shimizu and Hitoshi Uno. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical chemistry.

Conclusion

Haruki Nishimura's contributions to pharmaceutical chemistry through his patents and collaborations underscore his importance in the field. His innovative work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…